Hormonal therapeutics enzalutamide and abiraterone acetate in the treatment of metastatic castration-resistant prostate cancer (mCRPC) post-docetaxel-an indirect comparison

Hormonal therapeutics enzalutamide and abiraterone acetate in the treatment of metastatic castration-resistant prostate cancer (mCRPC) post-docetaxel-an indirect comparison

10.4137/CMO.S13671

Saved in:
Bibliographic Details
Main Authors: Tan, P.S., Haaland, B., Montero, A.J., Kyriakopoulos, C.E., Lopes, G.
Other Authors: DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
Format: Article
Published: 2016
Subjects:
Abiraterone acetate
Enzalutamide
mCRPC
Metastatic castration-resistant prostate cancer
Post-docetaxel
Online Access:http://scholarbank.nus.edu.sg/handle/10635/126501
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore

Internet

http://scholarbank.nus.edu.sg/handle/10635/126501

Similar Items